CTs of core muscle may help identify optimal treatments for older patients with hip fractures

NewsGuard 100/100 Score

Using computed tomography (CT) to evaluate muscle health may help identify optimal treatments for older patients who fall and break their hips, a new study led by radiologists from UC Davis and Wake Forest Baptist medical centers has found.

Published in the June issue of the American Journal of Roentgenology, the research specifically showed that decreased "core" muscle that stabilizes the spine was associated with decreased survival times following hip fractures.

While CTs of core muscle have been used to predict patient outcomes, the new study is the first to use the imaging technology to link survival with hip fractures, a common cause of injury, hospitalizations and disability among older Americans.

Doctors could potentially use information about muscle loss, known as sarcopenia, to determine a patient's level of frailty and guide treatment decisions, according to lead author Robert Boutin. A patient with favorable life expectancy, for instance, could be treated for hip fracture with total hip arthroplasty, resulting in lower reoperation rates, better hip function and better quality of life. In contrast, a patient with clinical and imaging features of frailty could benefit most from a simpler surgery.

"As patients age, it becomes increasingly important to identify the safest and most beneficial orthopedic treatments, but there currently is no objective way to do this," said Boutin, a UC Davis professor of radiology. "Using CT scans to evaluate muscles in addition to hip bones can help predict longevity and personalize treatment to a patient's needs. We're excited because information on muscle is included on every routine CT scan of the chest, abdomen, and pelvis, so the additional evaluations can be done without the costs of additional tests, equipment or software."

The study included nearly 300 people who were at least 65 years of age and treated for fall-related injuries at UC Davis Medical Center between 2005 and 2015. All were suspected of breaking their hips and received CTs to diagnose or rule out fracture.

The researchers evaluated the CTs with additional measurements of the size and density of lumbar and thoracic muscle alongside the spine. That information was then compared with mortality data from the National Death Index, a centralized database of death record information maintained by the U.S. Centers for Disease Control and Prevention.

The results showed that patients with better core muscle had significantly better survival rates over the duration of the 10-year study.

The study is especially important because most prior research on CTs of muscle has been in cancer patients and involved larger sample sizes, according to senior author Leon Lenchik.

"The fact that we were able to predict survival in such a small group of non-cancer patients is truly remarkable," said Lenchik, professor of radiology at Wake Forest.

The authors hope their research will inspire additional studies of sarcopenia, which is epidemic worldwide, and expand research focused on improving orthopedic treatments for older patients.

"Recognizing sarcopenia as a distinct condition that provides clues to future health can open doors to new discoveries in diagnosis and treatment," Boutin said.

Source: http://www.ucdmc.ucdavis.edu/publish/news/newsroom/12046

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers